TOP > 外国特許検索 > ANTICANCER AGENT AND INFUSION, METHOD FOR PRODUCING SAME, AND ANTICANCER SUBSTANCE

ANTICANCER AGENT AND INFUSION, METHOD FOR PRODUCING SAME, AND ANTICANCER SUBSTANCE コモンズ

外国特許コード F160008888
整理番号 (NU-0568)
掲載日 2016年10月25日
出願国 世界知的所有権機関(WIPO)
国際出願番号 2015JP006419
国際公開番号 WO 2016103695
国際出願日 平成27年12月23日(2015.12.23)
国際公開日 平成28年6月30日(2016.6.30)
優先権データ
  • 特願2014-261364 (2014.12.24) JP
発明の名称 (英語) ANTICANCER AGENT AND INFUSION, METHOD FOR PRODUCING SAME, AND ANTICANCER SUBSTANCE コモンズ
発明の概要(英語) [Problem] To provide an anticancer agent and infusion capable of selectively killing cancer cells with hardly any effect on normal cells and capable of being administered into a patient's body, a method for producing the same, and an anticancer substance. [Solution] The method for producing the anticancer agent has an aqueous solution preparation step and a plasma irradiation step. In the aqueous solution preparation step, prepared is a first aqueous solution containing at least one of lactic acid, sodium lactate, potassium lactate, calcium lactate, acetic acid, sodium acetate, potassium acetate, calcium acetate, citric acid, sodium citrate, potassium citrate, calcium citrate, potassium hydrogen carbonate, and calcium hydrogen carbonate. In the plasma irradiation step, the first aqueous solution is irradiated with plasma to provide a second aqueous solution.
特許請求の範囲(英語) [claim1]
1. The aqueous solution preparation process which prepares the 1st aqueous solution and,
Irradiating the plasma to the aforementioned 1st aqueous solution, the plasma lighting process which it makes the 2nd aqueous solution and,
Possessing,
As for the aforementioned 1st aqueous solution,
Lactic acid and the lactic acid sodium and the lactic acid kalium and the calcium lactate and acetic acid and sodium acetate and potassium acetate and calcium acetate and citric acid and the sodium citrate and the potassium citrate and citric acid calcium and potassium bicarbonate and carbonic acid hydrogen calcium and, contain at least one inside
Production method of the anti- cancer medicine which is featured.
[claim2]
2. In claim 1 in the production method of the anti- cancer medicine of statement,
As for the aforementioned 1st aqueous solution,
It is the ringer's solution
Production method of the anti- cancer medicine which is featured.
[claim3]
3. In claim 2 in the production method of the anti- cancer medicine of statement,
As for the aforementioned 1st aqueous solution,
It is the lactic acid ringer's solution
Production method of the anti- cancer medicine which is featured.
[claim4]
4. In claim 2 in the production method of the anti- cancer medicine of statement,
As for the aforementioned 1st aqueous solution,
It is the acetic acid ringer's solution
Production method of the anti- cancer medicine which is featured.
[claim5]
5. In claim 2 in the production method of the anti- cancer medicine of statement,
As for the aforementioned 1st aqueous solution,
It is heavy, it is the carbonic acid ringer's solution
Production method of the anti- cancer medicine which is featured.
[claim6]
6. From claim 1 either up to claim 5 in 1 sections in the production method of the anti- cancer medicine of statement,
As for the aforementioned 1st aqueous solution,
Sodium chloride and potassium chloride and calcium chloride and, contain at least one inside
Production method of the anti- cancer medicine which is featured.
[claim7]
7. From claim 1 either up to claim 6 in 1 sections in the production method of the anti- cancer medicine of statement,
Sodium chloride and potassium chloride and calcium chloride and, adding at least one inside to the aforementioned 2nd aqueous solution, possess the component addition process which it makes the 3rd aqueous solution
Production method of the anti- cancer medicine which is featured.
[claim8]
8. From claim 1 either up to claim 7 in 1 sections in the production method of the anti- cancer medicine of statement,
Possessing the frozen process which freezes the aforementioned 2nd aqueous solution or the aforementioned 3rd aqueous solution,
As for the aforementioned 2nd aqueous solution or the aforementioned 3rd aqueous solution,
Sodium chloride and potassium chloride and calcium chloride and, contain
Production method of the anti- cancer medicine which is featured.
[claim9]
9. In claim 8 in the production method of the anti- cancer medicine of statement,
With the aforementioned frozen process,
- Freeze the aforementioned 2nd aqueous solution or the aforementioned 3rd aqueous solution inside the range below the 0.deg.C above the 196.deg.C
Production method of the anti- cancer medicine which is featured.
[claim10]
10. From claim 1 either up to claim 9 in 1 sections in the production method of the anti- cancer medicine of statement,
With the aforementioned plasma lighting process,
As the 1st electrode which has the cartridge condition section is arranged outside the aforementioned 1st aqueous solution the 2nd electrode is arranged in the aforementioned 1st aqueous solution,
The gas is irradiated from the aforementioned cartridge condition section of the aforementioned 1st electrode facing toward the aforementioned 1st aqueous solution,
In the state impress voltage with the aforementioned 1st electrode and the aforementioned 2nd electrode
Production method of the anti- cancer medicine which is featured.
[claim11]
11. The aqueous solution preparation process which prepares the 1st aqueous solution and,
Irradiating the plasma to the aforementioned 1st aqueous solution, the plasma lighting process which it makes the 2nd aqueous solution and,
Possessing,
As for the aforementioned 1st aqueous solution,
Lactic acid and the lactic acid sodium and the lactic acid kalium and the calcium lactate and acetic acid and sodium acetate and potassium acetate and calcium acetate and citric acid and the sodium citrate and the potassium citrate and citric acid calcium and potassium bicarbonate and carbonic acid hydrogen calcium and, contain at least one inside
Production method of the transportation liquid which is featured.
[claim12]
12. Irradiating the plasma to the ringer's solution, it is something which is produced
The anti- cancer medicine which is featured.
[claim13]
13. Irradiating the plasma to the ringer's solution, it is something which is produced
The transportation liquid which is featured.
[claim14]
14. CH [3] CO or CH [3] possessing COCOO,
Become extinct the cancer cell selectively
The anti- cancer substance which is featured.
  • 出願人(英語)
  • ※2012年7月以前掲載分については米国以外のすべての指定国
  • NAGOYA UNIVERSITY
  • 発明者(英語)
  • MIZUNO MASAAKI
  • HORI MASARU
  • KIKKAWA FUMITAKA
  • KAJIYAMA HIROAKI
  • UTSUMI FUMI
  • NAKAMURA KAE
  • ISHIKAWA KENJI
  • TAKEDA KEIGO
  • TANAKA HIROMASA
  • KANO HIROYUKI
国際特許分類(IPC)
指定国 National States: AE AG AL AM AO AT AU AZ BA BB BG BH BN BR BW BY BZ CA CH CL CN CO CR CU CZ DE DK DM DO DZ EC EE EG ES FI GB GD GE GH GM GT HN HR HU ID IL IN IR IS JP KE KG KN KP KR KZ LA LC LK LR LS LU LY MA MD ME MG MK MN MW MX MY MZ NA NG NI NO NZ OM PA PE PG PH PL PT QA RO RS RU RW SA SC SD SE SG SK SL SM ST SV SY TH TJ TM TN TR TT TZ UA UG US UZ VC VN ZA ZM ZW
ARIPO: BW GH GM KE LR LS MW MZ NA RW SD SL SZ TZ UG ZM ZW
EAPO: AM AZ BY KG KZ RU TJ TM
EPO: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
OAPI: BF BJ CF CG CI CM GA GN GQ GW KM ML MR NE SN ST TD TG
名古屋大学の公開特許情報を掲載しています。ご関心のある案件がございましたら、下記まで電子メールでご連絡ください。

PAGE TOP

close
close
close
close
close
close